KATELYNN SINGH: Open Payments
NPI 1306543939 · FORNEY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$818 in 34 payments from 17 companies in 2025. Trend: 2023 $139 · 2024 $636 · 2025 $818
Food & beverage: $818
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $185 |
| Radius Health, Inc. | 4 | $84 |
| Lilly USA, LLC | 3 | $71 |
| SANOFI-AVENTIS U.S. LLC | 3 | $70 |
| Corcept Therapeutics | 3 | $61 |
| CSL Behring | 2 | $49 |
| Xeris Pharmaceuticals, Inc. | 2 | $46 |
| Neurocrine BioSciences, Inc. | 1 | $34 |
| RECORDATI_RARE_DISEASES_INC. | 2 | $34 |
| Blueprint Medicines Corporation | 1 | $32 |
Products named: Ozempic, Tymlos, MOUNJARO, TZIELD, Korlym, Hizentra, GVOKE HYPOPEN, CRENESSITY.
Industry payments across TX — which companies pay providers there.
